alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          OCT-31-2000
<PERIOD-START>                             JAN-30-2000
<PERIOD-END>                               APR-29-2000
<EXCHANGE-RATE>                                      1
<CASH>                                         100,848
<SECURITIES>                                         0
<RECEIVABLES>                                      479
<ALLOWANCES>                                        40
<INVENTORY>                                      2,588
<CURRENT-ASSETS>                               108,094
<PP&E>                                          44,567
<DEPRECIATION>                                  18,947
<TOTAL-ASSETS>                                 134,256
<CURRENT-LIABILITIES>                           11,946
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           249
<OTHER-SE>                                     120,310
<TOTAL-LIABILITY-AND-EQUITY>                   134,256
<SALES>                                            710
<TOTAL-REVENUES>                                   710
<CGS>                                            1,102
<TOTAL-COSTS>                                    1,102
<OTHER-EXPENSES>                                 8,143<F1>
<LOSS-PROVISION>                                  (14)
<INTEREST-EXPENSE>                                  17
<INCOME-PRETAX>                                (9,907)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (9,907)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (9,907)
<EPS-BASIC>                                     (0.42)
<EPS-DILUTED>                                        0
<FN>
<F1>OTHER EXPENSES are for R&D incurred in developing product for market
</FN>


</TABLE>
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.1930 Tonometer and accessories. ( a ) *Identification.* A tonometer and accessories is a manual device intended to measure intraocular pressure by applying a known force on the globe of the eye and measuring the amount of indentation produced (Schiotz type) or to measure intraocular tension by applanation (applying a small flat disk to the cornea). Accessories for the device may include a tonometer calibrator or a tonograph recording system. The device is intended for use in the diagnosis of glaucoma.
( b ) *Classification.* Class II.
# C_2017249EN.01000201.xml

| 31.7.2017 | EN | Official Journal of the European Union | C 249/2 |
| --- | --- | --- | --- |

31.7.2017

EN

Official Journal of the European Union

C 249/2

---

Judgment of the Court (Grand Chamber) of 30 May 2017 — Safa Nicu Sepahan Co. v Council of the European Union

(Case C-45/15 P) (1)

((Appeal - Action for damages - Common foreign and security policy (CFSP) - Restrictive measures against the Islamic Republic of Iran - List of persons and entities subject to the freezing of funds and economic resources - Material damage - Non-material damage - Error of assessment in respect of the amount of compensation - None - Cross-appeal - Conditions governing the incurring of the European Union’s non-contractual liability - Obligation to substantiate the restrictive measures - Sufficiently serious breach))

(2017/C 249/02)

Language of the case: English

Parties

Appellant: Safa Nicu Sepahan Co. (represented by: A. Bahrami, avocat)

Other party to the proceedings: Council of the European Union (represented by: R. Liudvinaviciute-Cordeiro, M. Bishop and I. Gurov, acting as Agents)

Intervener in support of the Council of the European Union: United Kingdom of Great Britain and Northern Ireland (represented by: M. Gray, acting as Agent)

Operative part of the judgment

The Court:

| 1. | Dismisses the appeals brought by Safa Nicu Sepahan Co. and the Council of the European Union; |
| --- | --- |

1.

Dismisses the appeals brought by Safa Nicu Sepahan Co. and the Council of the European Union;

| 2. | Orders Safa Nicu Sepahan Co. and the Council of the European Union to bear their own costs; |
| --- | --- |

2.

Orders Safa Nicu Sepahan Co. and the Council of the European Union to bear their own costs;

| 3. | Orders the United Kingdom of Great Britain and Northern Ireland to bear its own costs. |
| --- | --- |

3.

Orders the United Kingdom of Great Britain and Northern Ireland to bear its own costs.

---

(1)  
  OJ C 118, 13.4.2015.

---
### A l te r na t i ve m ode li ng ( D onovan N O 2/ N O x s tack ra t i o) S tev e H ill to: G e r a r do R i o s , C l e v e l and Ho ll ada y , Roge r Kohn,

S h i r l e yR i v e ra 05 /23 /2012 01 : 51 PM
C c: " W . D a v i d J en k i n s ( d j en k i n s @ ape x po w e rg roup
. c o m) " , G a ry R uben s t e in , " M c Ki n s e y , J ohn A. " , M agg i e F itz ge r a l d , " Fo s t e r, M e li ss a A. ( m a fo s t e r@ s t oe l. c o m) " , " M oo re , St e v e " , " H e llwi g , 

### Att ac h e d ar e t h e r e s u l t s o f t h e al te r n a t i v e a n al y sis r e qu e s te d b y E P A.
D a t a fil e s ar e b e i ngt ra n s m i tte d ph y sicall y. P l e as e l et m e k n o w if

y o u h a v e a n y qu e s t i o n s.

-- S te v e H ill Alt e r na ti v e D ono v an N O 2 -N O x M ode li ng 0512

. pdf
# C_2015007EN.01004501.xml

| 12.1.2015 | EN | Official Journal of the European Union | C 7/45 |
| --- | --- | --- | --- |

12.1.2015

EN

Official Journal of the European Union

C 7/45

---

Action brought on 17 November 2014 — Consolidated Artists v OHIM — Body Cosmetics International (MANGO)

(Case T-761/14)

(2015/C 007/51)

Language in which the application was lodged: French

Parties

Parties

Applicant: Consolidated Artists BV (Amstelveen, Netherlands) (represented by: B. Corne, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)

Defendant:

Other party to the proceedings before the Board of Appeal: Body Cosmetics International GmbH (Willich, Germany)

Other party to the proceedings before the Board of Appeal:

Details of the proceedings before OHIM

Details of the proceedings before OHIM

Proprietor of the trade mark at issue: Applicant

Proprietor of the trade mark at issue:

Trade mark at issue: Community figurative mark containing the word element ‘MANGO’

Trade mark at issue:

Procedure before OHIM: Proceedings for a declaration of invalidity

Procedure before OHIM

Contested decision: Decision of the Fourth Board of Appeal of OHIM of 8 September 2014 in Case R 2337/2013-4

Contested decision

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | order OHIM to pay the costs. |
| --- | --- |

—

order OHIM to pay the costs.

Plea in law

Plea in law

| — | Infringement of Articles 7(3) and 52(2) of Regulation No 207/2009. |
| --- | --- |

—

Infringement of Articles 7(3) and 52(2) of Regulation No 207/2009.

---
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.4370 Keratome. ( a ) *Identification.* A keratome is an AC-powered or battery-powered device intended to shave tissue from sections of the cornea for a lamellar (partial thickness) transplant.
( b ) *Classification.* Class I.
[55 FR 48443, Nov. 20, 1990]
§ 1.1411-6 Income on investment of working capital subject to tax. ( a ) *General rule.* For purposes of section 1411, any item of gross income from the investment of working capital will be treated as not derived in the ordinary course of a trade or business, and any net gain that is attributable to the investment of working capital will be treated as not derived in the ordinary course of a trade or business. In determining whether any item is gross income from or net gain attributable to an investment of working capital, principles similar to those described in § 1.469-2T(c)(3)(ii) apply. See § 1.1411-4(f) for rules regarding properly allocable deductions with respect to an investment of working capital and § 1.1411-7 for rules relating to the adjustment to net gain on the disposition of interests in a partnership or S corporation.
( b ) *Example.* The following example illustrates the principles of this section. Assume for purposes of the example that the taxpayer uses a calendar taxable year, the taxpayer is a United States citizen, and Year 1 and all subsequent years are taxable years in which section 1411 is in effect: Example. (i) A, an unmarried individual, operates a restaurant, which is a section 162 trade or business but is not a trade or business described in § 1.1411-5(a)(1) with respect to A. A owns and conducts the restaurant business through S, an S corporation wholly-owned by A. S is able to pay all of the restaurant's current obligations with cash flow generated by the restaurant. S utilizes an interest-bearing checking account at a local bank to make daily deposits of cash receipts generated by the restaurant, and also to pay the recurring ordinary and necessary business expenses of the restaurant. The average daily balance of the checking account is approximately $2,500, but at any given time the balance may be significantly more or less than this amount depending on the short-term cash flow needs of the business. In addition, S has set aside $20,000 for the potential future needs of the business in case the daily cash flow into and from the checking account becomes insufficient to pay the restaurant's recurring business expenses. S does not currently need to spend or use the $20,000 capital to conduct the restaurant business, and S deposits and maintains the $20,000 in an interest-bearing savings account at a local bank. (ii) Both the $2,500 average daily balance of the checking account and the $20,000 savings account balance constitute working capital under § 1.469-2T(c)(3)(ii) and, pursuant to paragraph (a) of this section, the interest generated by this working capital will not be treated as derived in the ordinary course of S's restaurant business. Accordingly, the interest income derived by S from its checking and savings accounts and allocated to A under section 1366 constitutes gross income from interest under § 1.1411-4(a)(1)(i).
( c ) *Effective/applicability date.* This section applies to taxable years beginning after December 31, 2013. However, taxpayers may apply this section to taxable years beginning after December 31, 2012, in accordance with § 1.1411-1(f).
[T.D. 9644, 78 FR 72424, Dec. 2, 2013]
EXHIBIT 32





CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)



Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of InZon Corporation a Nevada corporation (the Company), does hereby certify, to such officer's knowledge, that:



The Quarterly Report on Form 10-QSB for the quarter ended June 30, 2007 (the Form 10-QSB) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-QSB fairly presents, in all material respects, the financial condition and results of operations of the Company.





|                     |     |                        
|-------------------- | --- | -----------------------
|                     |     |                        
|Date August 14, 2007 | By: | /s/ David F. Levy      
|                     |     | David F. Levy          
|                     |     | Chief Executive Officer
|                     |     |                        





|                     |     |                        
|-------------------- | --- | -----------------------
|                     |     |                        
|Date August 14, 2007 | By: | /s/ Richard Dea        
|                     |     | Richard Dea            
|                     |     | Chief Financial Officer
|                     |     |
I 

118TH CONGRESS 

2D SESSION H. R. 7741 

To direct the President to oppose any waiver of obligations of members 

of the World Trade Organization under the Agreement on Trade-Related 

Aspects of Intellectual Property Rights unless a statute is enacted expressly authorizing such a waiver. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 20, 2024 

Mr. BURCHETT (for himself, Mr. FLEISCHMANN, Mr. GUEST, and Mr. RUTHERFORD) introduced the following bill; which was referred to the Committee on Ways and Means 

A BILL 

To direct the President to oppose any waiver of obligations 

of members of the World Trade Organization under the 

Agreement on Trade-Related Aspects of Intellectual 

Property Rights unless a statute is enacted expressly 

authorizing such a waiver. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Trade Related Intellec5 tual Property Protection Act’’ or the ‘‘TRIPP Act’’. 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7741 IH

1 SEC. 2. OPPOSITION TO WAIVER OF OBLIGATIONS OF WTO 

2 MEMBERS UNDER THE TRIPS AGREEMENT. 

3 The President shall oppose any waiver of obligations 

4 of members of the World Trade Organization under the 

5 TRIPS Agreement unless a statute is enacted expressly 

6 authorizing such a waiver. 

7 SEC. 3. TRIPS AGREEMENT DEFINED. 

8 In this Act, the term ‘‘TRIPS Agreement’’ means the 

9 Agreement on Trade-Related Aspects of Intellectual Prop10 erty Rights referred to in section 101(d)(15) of the Uru11 guay Round Agreements Act (19 U.S.C. 3511(d)(15)). 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
Exhibit 35.7



|     |  |  |                                            |                         
|---- |  |  | ------------------------------------------ | ------------------------
|LOGO |  |  |                                            | Corporate Trust Services
|     |  |  | MAC R1204-010                             
|     |  |  | 9062 Old Annapolis Road Columbia, MD 21045
|     |  |  | Tel: 410 884 2000                         
|     |  |  | Fax: 410 715 2380                         

Citibank, N.A.

388 Greenwich
Street

14th Floor

New York, New York 10013



|RE: | Annual Statement of Compliance for COMM 2015-CCRE24 Mortgage Trust Commercial Mortgage Pass-Through Certificates
|--- | ----------------------------------------------------------------------------------------------------------------

Per the Pooling and Servicing Agreement dated as of August 1, 2015 (the Agreement), the undersigned, a duly authorized officer of Wells Fargo
Bank, N.A., as Certificate Administrator (Wells Fargo), hereby certifies as follows as of and for the year ending December 31, 2015 (the Reporting Period):

(a) A review of Wells Fargos activities during the Reporting Period and of its performance under the Agreement has been made under such
officers supervision; and

(b) To the best of such officers knowledge, based on such review, Wells Fargo has fulfilled all of
its obligations under the Agreement in all material respects throughout the Reporting Period.

March 1, 2016



|              
|--------------
|LOGO          
|              
|BRIAN SMITH   
|Vice President



|                       |  |     
|---------------------- |  | ----
|Wells Fargo Bank, N.A. |  | LOGO
§ 884.1660 Transcervical endoscope (amnioscope) and accessories. ( a ) *Identification.* A transcervical endoscope is a device designed to permit direct viewing of the fetus and amniotic sac by means of an open tube introduced into the uterus through the cervix. The device may be used to visualize the fetus or amniotic fluid and to sample fetal blood or amniotic fluid. This generic type of device may include obturators, instruments used through an operating channel, light sources and cables, and component parts.
( b ) *Classification.* Class II (performance standards).
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.1660 Indicator injector. ( a ) *Identification.* An indicator injector is an electrically or gas-powered device designed to inject accurately an indicator solution into the blood stream. This device may be used in conjuction with a densitometer or thermodilution device to determine cardiac output.
( b ) *Classification.* Class II (performance standards).
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               JUN-30-1998
<CASH>                                        (14,948)
<SECURITIES>                                         0
<RECEIVABLES>                               15,924,475
<ALLOWANCES>                                 8,118,258
<INVENTORY>                                     77,250
<CURRENT-ASSETS>                             8,473,442
<PP&E>                                       1,494,334
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              10,424,810
<CURRENT-LIABILITIES>                        4,385,732
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    12,665,521
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                10,424,810
<SALES>                                      1,840,384
<TOTAL-REVENUES>                             1,840,384
<CGS>                                        2,236,604
<TOTAL-COSTS>                                2,236,604
<OTHER-EXPENSES>                              (16,907)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             206,978
<INCOME-PRETAX>                              (620,105)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (620,105)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (620,105)
<EPS-PRIMARY>                                    (0.5)
<EPS-DILUTED>                                    (0.5)
        

</TABLE>
1

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE 

STATE OF DELAWARE,

 Plaintiff, 

 v.

RONALD STOW,

 Defendant.

 

)

) 

) 

) 

) Cr. ID. No. 1910001001 

)

)

)

)

Submitted: May 1, 2023

Decided: May 17, 2023

On Defendant’s Motion for Post-Conviction Relief

DENIED

On Defendant’s Motion for Appointment of Counsel

DENIED

ORDER 

JOHNSTON, J.

On July 6, 2021, Ronald Stow (“Defendant”) pled guilty to four counts of 

Dealing in Child Pornography, and one count of Sex Offender Unlawful Sexual 

Conduct Against a Child. Defendant was sentenced on October 1, 2021. On 

August 12, 2022, Defendant requested transcripts of his sentencing hearing. The 

Court granted Defendant’s request and sent the sentencing transcript to Defendant 

on September 22, 2022. Defendant filed the instant Motion for Postconviction 

Relief, together with a Motion for Appointment of Counsel, on April 20, 2023. 
2

“A motion for postconviction relief may not be filed more than one year 

after the judgment of conviction is final . . . .”1 “A judgment of conviction is 

final . . . [30 days after the Court imposes sentence] if the defendant does not file a 

direct appeal.”2 Delaware Superior Court Rule 61(e)(3) states:

The judge may appoint counsel for an indigent movant’s 

first timely postconviction motion and request for 

appointment of counsel if the motion seeks to set aside a 

judgment of conviction that resulted from a plea of guilty 

or nolo contendere only if the judge determines that: (i) the 

conviction has been affirmed by final order upon direct 

appellate review or direct appellate review is unavailable; 

(ii) the motion sets forth a substantial claim that the 

movant received ineffective assistance of counsel in 

relation to the plea of guilty or nolo contendere; (iii) 

granting the motion would result in vacatur of the 

judgment of conviction for which the movant is in 

custody; and (iv) specific exceptional circumstances 

warrant the appointment of counsel.

The Court finds Defendant’s Motion for Post-Conviction Relief untimely. 

Thus, Rule 61(e)(3) also is not satisfied. While this is Defendant’s first postconviction motion, it is not timely. The Court imposed Defendant’s sentence on 

October 1, 2021. The judgment of conviction became final on October 31, 2021. 

Defendant did not file his motion for post-conviction relief until April 20, 2023—

nearly six months after the one-year deadline.3

1 Del. Super. Ct. R. 61(i)(1). 

2 Del. Super. Ct. R. 61(m)(1). 

3 The Court sent Defendant his sentencing transcript on September 22, 2022. Defendant had 

approximately one month after receiving his sentencing transcript to submit his Motion for PostConviction Relief in a timely manner. One month is more than enough time to submit the 
3

The Court hereby DENIES Defendant’s Motion for Post-Conviction Relief. 

The Court hereby DENIES Defendant’s Motion for Appointment of Counsel. 

IT IS SO ORDERED.

/s/ Mary M. Johnston

The Honorable Mary M. Johnston

motion in a timely fashion. Instead, Defendant submitted his motions almost six months after 

the one-year deadline.